688468 Stock Overview
Engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Chemclin Diagnostics Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.55 |
| 52 Week High | CN¥12.94 |
| 52 Week Low | CN¥5.80 |
| Beta | -0.077 |
| 11 Month Change | -12.08% |
| 3 Month Change | -15.59% |
| 1 Year Change | -28.02% |
| 33 Year Change | -70.25% |
| 5 Year Change | n/a |
| Change since IPO | -73.74% |
Recent News & Updates
Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance
May 06
Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Apr 30Shareholder Returns
| 688468 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.1% | -2.6% | -0.7% |
| 1Y | -28.0% | -15.4% | -14.6% |
Return vs Industry: 688468 underperformed the CN Medical Equipment industry which returned -15.4% over the past year.
Return vs Market: 688468 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 688468 volatility | |
|---|---|
| 688468 Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 688468 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688468's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 731 | n/a | www.chemclin.com |
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.
Chemclin Diagnostics Co., Ltd. Fundamentals Summary
| 688468 fundamental statistics | |
|---|---|
| Market cap | CN¥2.59b |
| Earnings (TTM) | CN¥150.93m |
| Revenue (TTM) | CN¥455.80m |
17.2x
P/E Ratio5.7x
P/S RatioIs 688468 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688468 income statement (TTM) | |
|---|---|
| Revenue | CN¥455.80m |
| Cost of Revenue | CN¥110.73m |
| Gross Profit | CN¥345.07m |
| Other Expenses | CN¥194.14m |
| Earnings | CN¥150.93m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 75.71% |
| Net Profit Margin | 33.11% |
| Debt/Equity Ratio | 15.8% |
How did 688468 perform over the long term?
See historical performance and comparison